Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1987-03-05
1989-11-28
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514530, 514913, A61K 3708, A61K 31215
Patent
active
048838195
ABSTRACT:
This invention provides a method for treating hypertension or glaucoma in a subject's eye which comprises contacting the surface of the eye with an effective intraocular pressure reducing amount of one or more prostaglandins selected from the group consisting of prostaglandin A (PGA), prostaglandin B (PGB), prostaglandin C (PGC), derivatives of PGA, PGB, and PGC, conjugates of PGA and conjugated derivatives of PGA, so as to reduce the intraocular pressure of the eye and maintain such reduced intraocular pressure. Also provided is a composition for topical treatment of hypertension or glaucoma in the eye of a subject which comprises an effective intraocular pressure reducing amount of one or more prostaglandins selected from the group consisting of PGA, PGB and PGC, derivatives of PGA, PGB and PGC and conjugates of PGA and an opthalmically compatible carrier.
REFERENCES:
patent: 4004027 (1977-01-01), Lippmann et al.
patent: 4070482 (1978-01-01), Lippmann et al.
patent: 4097496 (1978-06-01), Babej et al.
patent: 4112225 (1978-09-01), Holland et al.
patent: 4311707 (1982-01-01), Birnbaum et al.
patent: 4564637 (1986-01-01), Schachar
patent: 4599353 (1986-07-01), Bito
Chemistry, Biochemistry & Pharmaeological Acitivity of Prostanoids, pp. 1 & 4, 1978, Horton.
Chem. Abst., 71:120122(a), (1969) Beitch et al.
Chem. Abst., 78:80097(k) (1973), Nakano et al.
Chem. Abst., 80:44231(g) (1974), Chiang.
Chem. Abst., 81:21424(d) (1974), Chiang.
Chem. Abst., 81:45653(d) (1974), Masuda et al.
Chem. Abst. 102:161111(b) (1985), Trzeciakowski et al.
Beitch et al., The Effects of Prostaglandins on the Intraocular Pressure of the Rabbit, Br. J. Pharmac, 37, 158-167 (1969).
Nakano et al., Effects of Prostaglandins E1, E2, A1, A2 and F2 on Canine Carotid Arterial Blood Flow, Cerebrospinal Fluid Pressure, and Intraocular Pressure, J. Neurosurg, 38, 32-39 (1973).
Chiang, Effects of Epinephrine and Progesterone on the Ocular Hypertensive Response to Intravenous Infusion of Prostaglandin A2, Prost. 4(3), 415-419 (1973).
Chiang, Effects of Intravenous Infusions of Histamine 5-Hydroxytryptamine, Bradykinin and Prostaglandins on Intraocular Pressure, Arch. int. Pharmacodyn, 207, 131-138 (1974).
Masuda et al., Effects of Prostaglandins on Inflow and Outflow of the Aqueous Humor in Rabbits, Jap. J. Opthalmol, 17(4), 300-309 (1974).
Trjeciakowski et al., Effects of Prostaglandins on Intraocular Pressure Recovery Rate in Rabbits, Prest. 29(3), 497-510 (1985).
Fay Zohreh
Robinson Douglas W.
The Trustees of Columbia University in the City of New York
White John P.
LandOfFree
Use of A, B and C prostaglandins and derivatives thereof to trea does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of A, B and C prostaglandins and derivatives thereof to trea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of A, B and C prostaglandins and derivatives thereof to trea will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-582359